Gene transfer to carcinoma of the breast with fiber-modified adenoviral vectors in a tissue slice model system

Mariam A. Stoff-Khalili, Alexander Stoff, Angel A. Rivera, J. Michael Mathis, Maaike Everts, Minghui Wang, Yosuke Kawakami, Reinhard Waehler, Quiana L. Mathews, Masato Yamamoto, Rodney P. Rocconi, Gene P. Siegal, Dirk F. Richter, Peter Dall, Zeng B. Zhu, David T. Curiel

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Successful adenoviral (Ad) vector-mediated strategies for breast cancer gene therapy and virotherapy have heretofore been hindered by low transduction efficiency. This has recently been understood to result from a relative paucity of expression of the primary adenovirus receptor, coxsackie-adenovirus-receptor (CAR), on primary tumor cells. To further investigate this issue, we evaluated the expression of CAR on breast cancer cell lines as well as primary breast cancer cells. With the exception of one patient sample, CAR expression was notably higher in the tumor cells from patients compared to CAR expression in the tumor cell lines. Furthermore, we explored CAR-independent targeting strategies to breast cancer tissue by exploring a panel of infectivity-enhanced Ad vectors, which contain CAR-independent targeting motifs for their utility in breast cancer gene therapy and virotherapy. These targeting motifs included Ad 3 knob (Ad5/3), canine Ad serotype 2 knob (Ad5CAV-2), RGD (Ad5.RGD), polylysine (Ad5.pK7), or both RGD and polylysine (Ad5.RGD.pK7), and were tested using the breast cancer tissue slice model, which is the most stringent substrate system available. Of all the tested tropism modified Ad vectors, Ad5/3 exhibited the highest transductional efficiency in breast cancer. These preclinical results suggest that Ad5/3 is the most useful modification to achieve higher clinical efficacy of breast cancer gene therapy and virotherapy.

Original languageEnglish
Pages (from-to)1203-1210
Number of pages8
JournalCancer Biology and Therapy
Volume4
Issue number11
StatePublished - Nov 2005

Fingerprint

Coxsackie and Adenovirus Receptor-Like Membrane Protein
Breast Neoplasms
Genes
Neoplasm Genes
Genetic Therapy
Polylysine
Tropism
Tumor Cell Line
Canidae
Neoplasms
Cell Line

Keywords

  • Ad5/3
  • Adenovirus
  • Breast cancer
  • Fiber modification
  • Gene therapy
  • Model
  • Transductional targeting

Cite this

Stoff-Khalili, M. A., Stoff, A., Rivera, A. A., Mathis, J. M., Everts, M., Wang, M., ... Curiel, D. T. (2005). Gene transfer to carcinoma of the breast with fiber-modified adenoviral vectors in a tissue slice model system. Cancer Biology and Therapy, 4(11), 1203-1210.
Stoff-Khalili, Mariam A. ; Stoff, Alexander ; Rivera, Angel A. ; Mathis, J. Michael ; Everts, Maaike ; Wang, Minghui ; Kawakami, Yosuke ; Waehler, Reinhard ; Mathews, Quiana L. ; Yamamoto, Masato ; Rocconi, Rodney P. ; Siegal, Gene P. ; Richter, Dirk F. ; Dall, Peter ; Zhu, Zeng B. ; Curiel, David T. / Gene transfer to carcinoma of the breast with fiber-modified adenoviral vectors in a tissue slice model system. In: Cancer Biology and Therapy. 2005 ; Vol. 4, No. 11. pp. 1203-1210.
@article{c747b1080f23472c9345a0d746b381a9,
title = "Gene transfer to carcinoma of the breast with fiber-modified adenoviral vectors in a tissue slice model system",
abstract = "Successful adenoviral (Ad) vector-mediated strategies for breast cancer gene therapy and virotherapy have heretofore been hindered by low transduction efficiency. This has recently been understood to result from a relative paucity of expression of the primary adenovirus receptor, coxsackie-adenovirus-receptor (CAR), on primary tumor cells. To further investigate this issue, we evaluated the expression of CAR on breast cancer cell lines as well as primary breast cancer cells. With the exception of one patient sample, CAR expression was notably higher in the tumor cells from patients compared to CAR expression in the tumor cell lines. Furthermore, we explored CAR-independent targeting strategies to breast cancer tissue by exploring a panel of infectivity-enhanced Ad vectors, which contain CAR-independent targeting motifs for their utility in breast cancer gene therapy and virotherapy. These targeting motifs included Ad 3 knob (Ad5/3), canine Ad serotype 2 knob (Ad5CAV-2), RGD (Ad5.RGD), polylysine (Ad5.pK7), or both RGD and polylysine (Ad5.RGD.pK7), and were tested using the breast cancer tissue slice model, which is the most stringent substrate system available. Of all the tested tropism modified Ad vectors, Ad5/3 exhibited the highest transductional efficiency in breast cancer. These preclinical results suggest that Ad5/3 is the most useful modification to achieve higher clinical efficacy of breast cancer gene therapy and virotherapy.",
keywords = "Ad5/3, Adenovirus, Breast cancer, Fiber modification, Gene therapy, Model, Transductional targeting",
author = "Stoff-Khalili, {Mariam A.} and Alexander Stoff and Rivera, {Angel A.} and Mathis, {J. Michael} and Maaike Everts and Minghui Wang and Yosuke Kawakami and Reinhard Waehler and Mathews, {Quiana L.} and Masato Yamamoto and Rocconi, {Rodney P.} and Siegal, {Gene P.} and Richter, {Dirk F.} and Peter Dall and Zhu, {Zeng B.} and Curiel, {David T.}",
year = "2005",
month = "11",
language = "English",
volume = "4",
pages = "1203--1210",
journal = "Cancer Biology and Therapy",
issn = "1538-4047",
publisher = "Landes Bioscience",
number = "11",

}

Stoff-Khalili, MA, Stoff, A, Rivera, AA, Mathis, JM, Everts, M, Wang, M, Kawakami, Y, Waehler, R, Mathews, QL, Yamamoto, M, Rocconi, RP, Siegal, GP, Richter, DF, Dall, P, Zhu, ZB & Curiel, DT 2005, 'Gene transfer to carcinoma of the breast with fiber-modified adenoviral vectors in a tissue slice model system', Cancer Biology and Therapy, vol. 4, no. 11, pp. 1203-1210.

Gene transfer to carcinoma of the breast with fiber-modified adenoviral vectors in a tissue slice model system. / Stoff-Khalili, Mariam A.; Stoff, Alexander; Rivera, Angel A.; Mathis, J. Michael; Everts, Maaike; Wang, Minghui; Kawakami, Yosuke; Waehler, Reinhard; Mathews, Quiana L.; Yamamoto, Masato; Rocconi, Rodney P.; Siegal, Gene P.; Richter, Dirk F.; Dall, Peter; Zhu, Zeng B.; Curiel, David T.

In: Cancer Biology and Therapy, Vol. 4, No. 11, 11.2005, p. 1203-1210.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Gene transfer to carcinoma of the breast with fiber-modified adenoviral vectors in a tissue slice model system

AU - Stoff-Khalili, Mariam A.

AU - Stoff, Alexander

AU - Rivera, Angel A.

AU - Mathis, J. Michael

AU - Everts, Maaike

AU - Wang, Minghui

AU - Kawakami, Yosuke

AU - Waehler, Reinhard

AU - Mathews, Quiana L.

AU - Yamamoto, Masato

AU - Rocconi, Rodney P.

AU - Siegal, Gene P.

AU - Richter, Dirk F.

AU - Dall, Peter

AU - Zhu, Zeng B.

AU - Curiel, David T.

PY - 2005/11

Y1 - 2005/11

N2 - Successful adenoviral (Ad) vector-mediated strategies for breast cancer gene therapy and virotherapy have heretofore been hindered by low transduction efficiency. This has recently been understood to result from a relative paucity of expression of the primary adenovirus receptor, coxsackie-adenovirus-receptor (CAR), on primary tumor cells. To further investigate this issue, we evaluated the expression of CAR on breast cancer cell lines as well as primary breast cancer cells. With the exception of one patient sample, CAR expression was notably higher in the tumor cells from patients compared to CAR expression in the tumor cell lines. Furthermore, we explored CAR-independent targeting strategies to breast cancer tissue by exploring a panel of infectivity-enhanced Ad vectors, which contain CAR-independent targeting motifs for their utility in breast cancer gene therapy and virotherapy. These targeting motifs included Ad 3 knob (Ad5/3), canine Ad serotype 2 knob (Ad5CAV-2), RGD (Ad5.RGD), polylysine (Ad5.pK7), or both RGD and polylysine (Ad5.RGD.pK7), and were tested using the breast cancer tissue slice model, which is the most stringent substrate system available. Of all the tested tropism modified Ad vectors, Ad5/3 exhibited the highest transductional efficiency in breast cancer. These preclinical results suggest that Ad5/3 is the most useful modification to achieve higher clinical efficacy of breast cancer gene therapy and virotherapy.

AB - Successful adenoviral (Ad) vector-mediated strategies for breast cancer gene therapy and virotherapy have heretofore been hindered by low transduction efficiency. This has recently been understood to result from a relative paucity of expression of the primary adenovirus receptor, coxsackie-adenovirus-receptor (CAR), on primary tumor cells. To further investigate this issue, we evaluated the expression of CAR on breast cancer cell lines as well as primary breast cancer cells. With the exception of one patient sample, CAR expression was notably higher in the tumor cells from patients compared to CAR expression in the tumor cell lines. Furthermore, we explored CAR-independent targeting strategies to breast cancer tissue by exploring a panel of infectivity-enhanced Ad vectors, which contain CAR-independent targeting motifs for their utility in breast cancer gene therapy and virotherapy. These targeting motifs included Ad 3 knob (Ad5/3), canine Ad serotype 2 knob (Ad5CAV-2), RGD (Ad5.RGD), polylysine (Ad5.pK7), or both RGD and polylysine (Ad5.RGD.pK7), and were tested using the breast cancer tissue slice model, which is the most stringent substrate system available. Of all the tested tropism modified Ad vectors, Ad5/3 exhibited the highest transductional efficiency in breast cancer. These preclinical results suggest that Ad5/3 is the most useful modification to achieve higher clinical efficacy of breast cancer gene therapy and virotherapy.

KW - Ad5/3

KW - Adenovirus

KW - Breast cancer

KW - Fiber modification

KW - Gene therapy

KW - Model

KW - Transductional targeting

UR - http://www.scopus.com/inward/record.url?scp=33644648085&partnerID=8YFLogxK

M3 - Article

C2 - 16177567

AN - SCOPUS:33644648085

VL - 4

SP - 1203

EP - 1210

JO - Cancer Biology and Therapy

JF - Cancer Biology and Therapy

SN - 1538-4047

IS - 11

ER -